CMS announces “top 10” costly drugs list selected for price negotiations
Two weeks ago, the Centers for Medicare & Medicaid Services (CMS) announced the first 10 brand name medications that it will negotiate Medicare Part D prices directly with drug manufacturers to take effect starting in 2026. Several of these medications are commonly prescribed by primary care physicians and were discussed in American Family Physician’s S…
Keep reading with a 7-day free trial
Subscribe to Common Sense Family Doctor to keep reading this post and get 7 days of free access to the full post archives.